The Saudi Public Health Authority announced a mechanism for documenting the acquisition of one of the new vaccines against the emerging corona virus (Covid-19) approved in the Kingdom of Saudi Arabia, whether for citizens and residents, or immunized travelers coming to the Kingdom.
The authority published, through its Twitter account, the mechanism for documenting access to one of the vaccines approved in the Kingdom.
Citizens and residents
Anyone who appears to be “immune” in the “Tawakalna” app.
It includes those who completed the two full doses of the Corona vaccine, those who received one dose, provided that 14 days have passed since they were vaccinated with the first dose, and those recovering for a period not exceeding 6 months, as shown in the “Tawakolna” application.
Immunized travelers coming to the Kingdom
Citizens of the Gulf Cooperation Council countries, and holders of new visas of all kinds, vaccinations are registered electronically on the website: https://muqeem.sa/#/vaccine-registration/home.
Registration is only available for those who have met the following approved doses of vaccines: two doses each of “Pfizer”, “AstraZeneca” and “Moderna”, and one dose of “Johnson & Johnson” vaccine, with proof of this being presented upon arrival.
A person who received a single dose of the vaccines “Pfizer”, “Moderna” and “AstraZeneca” cannot register on the site, and the institutional quarantine will be applied to him upon his arrival.